HCS PHARMA

Loos, France

HCS Pharma is revolutionising drug discovery with a unique 3D cell technology, BIOMIMESYS®

$2.2M raised

Mar 2022

Initial Coin Offering

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has HCS PHARMA raised?

HCS PHARMA has raised $2.2M in total funding. The most recent round was Initial Coin Offering. The last funding was announced in March 2022.

Who are HCS PHARMA's investors?

HCS PHARMA's investors include The Global Emerging Markets Group, Eurasante.

Where is HCS PHARMA headquartered?

HCS PHARMA is headquartered in Loos, France.

What does HCS PHARMA do?

HCS Pharma is revolutionising drug discovery with a unique 3D cell technology, BIOMIMESYS®

What stage is HCS PHARMA at?

HCS PHARMA is at the Initial Coin Offering stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2022.

MLA

"HCS PHARMA — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/hcs-pharma. Accessed July 2, 2026.

APA

VCBacked. (2022). HCS PHARMA — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/hcs-pharma

Wikipedia (cite web)

{{cite web |title=HCS PHARMA — Funding & Investors |url=https://www.vcbacked.co/company/hcs-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2022.